Viewing Study NCT02312557

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:36 PM
Ignite Modification Date: 2026-02-27 @ 8:48 AM
Study NCT ID: NCT02312557
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-03
First Post: 2014-12-04
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide
Sponsor: OHSU Knight Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Castration-Resistant Prostate Carcinoma View
None Hormone-Resistant Prostate Cancer View
None PSA Progression View
None Recurrent Prostate Carcinoma View
None Stage IV Prostate Adenocarcinoma Cancer AJCC v8 View
Keywords: